ISPOR

Dr. Renée JG Arnold and 35 other HEOR professionals (ISPOR – Founding Leaders) founded ISPOR, originally called APOR (Association for Pharmacoeconomics and Outcomes Research) in 1995. It is now a global, 10,000 plus-strong organization dedicated to advancing HEOR excellence to improve decision making for health globally. Dr. Arnold was responsible for originating much of the educational structure of ISPOR–the short courses, abstract review committee, distance learning program and early coursework. She also founded the Open Source Models Special Interest Group in 2018 (transferred in 2024 to the Society for Medical Decision Making (SMDM), for which she received a leadership award, and presented at/chaired many ISPOR sessions, including being a featured speaker at the 2021 Women in HEOR session, both in the US and OUS. To learn more, click here!
Society for Medical Decision Making (SMDM)
Dr. Arnold founded the Open Source Models Special Interest Group at the SMDM in 2024. Since being awarded Phase I of the SBIR Grant entitled “Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer”, SMDM has appeared to be especially open to collaborating with ACT in this endeavor. The SMDM OSM SIG has hosted several well-attended webinars and will be actively participating in the SMDM Annual Meeting to be held in Oslo, 2026.
BioHealth Innovation, Inc. and the National Institutes of Health (NIH)/National Heart, Lung and Blood Institute (NHLBI)

Since December, 2020, Dr. Arnold has been Entrepreneur-in-Residence, BioHealth Innovation and NIH/NHLBI, with expertise in Health Economics and Outcomes Research (HEOR) and reimbursement. In addition to providing a multitude of individual consults to both NHLBI and Catalyze awardees in her field of expertise, she has been responsible for leading engagements for NIH with organizations such as Springboard—(Springboard & NIH: Accelerating Tech Success Stories & Resources Webinar – Springboard Enterprises | Helping Women Raise & Rise) to enhance their awareness of nondilutive funding sources such as the NIH.
